Preliminary Novel Analysis on Antimicrobial Properties of Concentrated Growth Factor against Bacteria-Induced Oral Diseases

被引:4
|
作者
Alauddin, Muhammad Syafiq [1 ]
Yusof, Nabilah Mohd [2 ]
Adnan, Aini Sufinah [2 ]
Said, Zulfahmi [3 ]
机构
[1] Univ Sains Islam Malaysia, Dept Conservat Dent & Prosthodont, Fac Dent, Kuala Lumpur, Malaysia
[2] Univ Sains Islam Malaysia, Fac Dent, Kuala Lumpur, Malaysia
[3] Univ Sains Islam Malaysia, Dept Basic Sci & Oral Biol, Fac Dent, Kuala Lumpur, Malaysia
关键词
antibiofilm; concentrated growth factor; oral pathogen; platelet-rich concentrate; antibacterial; STAPHYLOCOCCUS-AUREUS MRSA; INFECTIONS; PLATELETS;
D O I
10.1055/s-0041-1742121
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objective Concentrated growth factor (CGF) is particularly gaining acceptance and popularity in regenerative dentistry. Nonetheless, there are no available studies showing its effect against microorganisms of oral cavity particularly in chronic oral disease-induced biofilms. This in vitro research was conducted to determine the antimicrobial effects of CGF against Staphylococcus aureus sp. ( S. aureus ) and Streptococcus mutans sp. ( S. mutans ). Materials and Methods Blood samples were obtained from a healthy volunteer. CGF was then prepared using specialized centrifugation equipment (Medifuge, Silfradent, Santa Sofia FC, Italy) and protocol. Antimicrobial activity of the CGF was observed and recorded on standard strains of S. aureus and S. mutans using a well diffusion method to determine the inhibition zone, broth microdilution to determine minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), and crystal violet assay for biofilm assessment, with chlorhexidine (CHX) 0.12% used as a positive control. Statistical analysis was then performed using one-way analysis of variance followed by Tukey Test post hoc analysis. Results It was observed that there was a presence of clear zones of inhibition around the CGF after 24hours of incubation. The mean diameter of the inhibition zone was 1.260.12nm and 1.20 +/- 0.06nm for S. aureus and S. mutans , respectively, with significance difference ( p <0.05) against the control group CHX 0.12%. The MIC values of the CGF against S. aureus and S. mutans were 47.9% and 34.17%, respectively, and the MBC values of the CGF against S. aureus and S. mutans were 100%. The viability and the ability in inhibiting the biofilm formation of S. mutans and S. aureus following treatment with CGF showed a reduction in the concentration-dependent manner as compared with the control group. Conclusion CGF possesses antimicrobial and antibiofilm activity against S. aureus and S. mutans .
引用
收藏
页码:901 / 910
页数:10
相关论文
共 49 条
  • [21] The Application of a Recombinant Antimicrobial Peptide Thrombocidin-1 Expressed in Pichia pastoris as a Novel Approach Against Some Oral Pathogenic Bacteria: An In Vitro Study
    Forouzanfar, Fatemeh
    Mohammadipour, Hamideh Sadat
    Akbari, Majid
    Beyraghshamshir, Reza
    Tanhaeian, Abbas
    Karimian, Elnaz
    PROTEIN AND PEPTIDE LETTERS, 2022, 29 (01): : 102 - 109
  • [22] INHIBITORY EFFECTS OF A BACTERIA-DERIVED SULFATED POLYSACCHARIDE AGAINST BASIC FIBROBLAST GROWTH FACTOR-INDUCED ENDOTHELIAL-CELL GROWTH AND CHEMOTAXIS
    NAKAYAMA, Y
    IWAHANA, M
    SAKAMOTO, N
    TANAKA, NG
    OSADA, Y
    JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 154 (01) : 1 - 6
  • [23] The protective effect of a novel transforming growth factor-β receptor inhibitor against radiation-induced fibrosis
    Park, Jin-hong
    Ryu, Seung-Hee
    Oh, Jeong-Yoon
    Yang, Youn-Joo
    Lee, Sang-Wook
    CANCER RESEARCH, 2011, 71
  • [24] A novel approach using growth curve analysis to distinguish between antimicrobial and anti-biofilm activities against Salmonella
    Sternisa, Meta
    Sabotic, Jerica
    Klancnik, Anja
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2022, 364
  • [25] Computational Design and Preliminary Serological Analysis of a Novel Multi-Epitope Vaccine Candidate Against Onchocerciasis and Related Filarial Diseases
    Shey, Robert Adamu
    Ghogomu, Stephen Mbigha
    Shintouo, Cabirou Mounchili
    Nkemngo, Francis Nongley
    Nebangwa, Derrick Neba
    Esoh, Kevin
    Yaah, Ntang Emmaculate
    Manka'aFri, Muyanui
    Nguve, Joel Ebai
    Ngwese, Roland Akwelle
    Njume, Ferdinand Ngale
    Bertha, Fru Asa
    Ayong, Lawrence
    Njemini, Rose
    Vanhamme, Luc
    Souopgui, Jacob
    PATHOGENS, 2021, 10 (02): : 1 - 32
  • [26] The Interaction of Implant Luting Cements and Oral Bacteria Linked to Peri-Implant Disease: An In Vitro Analysis of Planktonic and Biofilm Growth - A Preliminary Study
    Raval, Neal C.
    Wadhwani, Chandur P. K.
    Jain, Sumita
    Darveau, Richard P.
    CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH, 2015, 17 (06) : 1029 - 1035
  • [27] Microenvironment Influence of a Novel Bioengineered Wound Product, APIS®: A Preliminary In Vitro Analysis of Inflammatory Marker and Growth Factor Secretion
    Rodriguez, Isaac
    Conti, Tricia
    Bionda, Nina
    INTERNATIONAL JOURNAL OF BIOMATERIALS, 2021, 2021
  • [28] Molecular Docking and Molecular Dynamic Investigations of Xanthone-Chalcone Derivatives against Epidermal Growth Factor Receptor for Preliminary Discovery of Novel Anticancer Agent
    Kurniawan, Yehezkiel Steven
    Yudha, Ervan
    Nugraha, Gerry
    Fatmasari, Nela
    Pranowo, Harno Dwi
    Jumina, Jumina
    Sholikhah, Eti Nurwening
    INDONESIAN JOURNAL OF CHEMISTRY, 2024, 24 (01) : 250 - 266
  • [29] PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration
    Wood, JM
    Bold, G
    Buchdunger, E
    Cozens, R
    Ferrari, S
    Frei, J
    Hofmann, F
    Mestan, J
    Mett, H
    O'Reilly, T
    Persohn, E
    Rösel, J
    Schnell, C
    Stover, D
    Theuer, A
    Towbin, H
    Wenger, F
    Woods-Cook, K
    Menrad, A
    Siemeister, G
    Schirner, M
    Thierauch, KH
    Schneider, MR
    Drevs, J
    Martiny-Baron, G
    Totzke, F
    Marmé, D
    CANCER RESEARCH, 2000, 60 (08) : 2178 - 2189
  • [30] A novel single-chain-Fv antibody against connective tissue growth factor attenuates bleomycin-induced pulmonary fibrosis in mice
    Wang, Xihua
    Wu, Guoqiu
    Gou, Lixia
    Liu, Zhaozhao
    Wang, Xiyong
    Fan, Xiaobo
    Wu, Linyuan
    Liu, Naifeng
    RESPIROLOGY, 2011, 16 (03) : 500 - 507